Half Yearly Results Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
3,620.87
3,209.71
3,081.08
2,737.15
2,618.35
2,798.41
2,189.79
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,620.87
3,209.71
3,081.08
2,737.15
2,618.35
2,798.41
2,189.79
Raw Material Cost
894.41
799.07
748.06
608.72
537.85
581.38
471.78
Purchase of Finished goods
235.98
198.14
178.92
218.46
194.18
120.88
177.19
(Increase) / Decrease In Stocks
-207.06
-174.00
-52.02
-5.88
-14.06
-52.50
-171.95
Employee Cost
860.31
771.24
695.16
580.20
583.06
551.44
432.62
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
1,240.19
1,139.17
1,104.02
1,088.26
824.16
746.43
709.72
Total Expenditure (Excl Depreciation)
3,023.83
2,733.62
2,674.14
2,489.76
2,125.19
1,947.63
1,619.36
Operating Profit (PBDIT) excl Other Income
597.04
476.09
406.94
247.39
493.16
850.78
570.43
Other Income
13.41
18.85
21.82
1.41
4.08
3.54
3.65
Operating Profit (PBDIT)
610.45
494.94
428.76
248.80
497.24
854.32
574.08
Interest
47.75
31.99
30.08
21.20
6.70
11.15
12.05
Exceptional Items
0.00
12.87
0.00
0.00
0.00
0.00
-32.79
Gross Profit (PBDT)
562.70
475.82
398.68
227.60
490.54
843.17
529.24
Depreciation
149.84
139.55
133.74
134.80
107.75
85.28
71.35
Profit Before Tax
412.86
336.27
264.94
92.80
382.79
757.89
457.89
Tax
76.49
49.76
7.24
16.46
73.71
139.75
88.44
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
336.37
286.51
257.70
76.34
309.08
618.14
369.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
336.37
286.51
257.70
76.34
309.08
618.14
369.45
Share in Profit of Associates
0.97
1.18
-0.54
-8.87
13.17
0.28
0.49
Minority Interest
1.75
0.43
0.00
0.00
11.55
16.40
0.06
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
339.09
288.12
257.16
67.47
333.80
634.82
370.00
Equity Capital
39.31
39.31
39.31
39.31
39.31
39.31
37.70
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
5,148.00
4,540.31
2,924.45
Earnings per share (EPS)
17.25
14.66
13.08
3.43
16.98
32.3
19.63
Diluted Earnings per share
17.25
14.64
13.08
3.43
16.98
33.25
19.63
Operating Profit Margin (Excl OI)
16.49%
14.83%
13.21%
9.04%
18.83%
30.4%
26.05%
Gross Profit Margin
15.54%
14.82%
12.94%
8.32%
18.73%
30.13%
24.17%
PAT Margin
9.32%
8.96%
8.35%
2.79%
11.8%
22.09%
16.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 12.81% vs 4.17% in Sep 2024
Consolidate Net Profit
Growth in half year ended Sep 2025 is 17.69% vs 12.04% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 25.40% vs 16.99% in Sep 2024
Interest
Growth in half year ended Sep 2025 is 49.27% vs 6.35% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has improved from Sep 2024
Compare Half Yearly Results Of Alembic Pharma With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
3,620.87
1,033.89
2,586.98
250.22%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,620.87
1,033.89
2,586.98
250.22%
Raw Material Cost
894.41
363.04
531.37
146.37%
Purchase of Finished goods
235.98
0.00
235.98
(Increase) / Decrease In Stocks
-207.06
-81.80
-125.26
-153.13%
Employee Cost
860.31
323.41
536.90
166.01%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1,240.19
162.49
1,077.70
663.24%
Total Expenditure (Excl Depreciation)
3,023.83
767.13
2,256.70
294.17%
Operating Profit (PBDIT) excl Other Income
597.04
266.76
330.28
123.81%
Other Income
13.41
25.23
-11.82
-46.85%
Operating Profit (PBDIT)
610.45
291.99
318.46
109.07%
Interest
47.75
21.72
26.03
119.84%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
562.70
270.27
292.43
108.20%
Depreciation
149.84
77.47
72.37
93.42%
Profit Before Tax
412.86
192.80
220.06
114.14%
Tax
76.49
48.50
27.99
57.71%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
336.37
144.30
192.07
133.10%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
336.37
144.30
192.07
133.10%
Share in Profit of Associates
0.97
0.00
0.97
Minority Interest
1.75
0.00
1.75
Other related items
0.00
0.00
0.00
Consolidated Net Profit
339.09
144.30
194.79
134.99%
Equity Capital
39.31
20.98
18.33
87.37%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
17.25
6.88
10.37
150.73%
Diluted Earnings per share
17.25
6.78
10.47
154.42%
Operating Profit Margin (Excl OI)
16.49%
25.80%
0.00
-9.31%
Gross Profit Margin
15.54%
26.14%
0.00
-10.60%
PAT Margin
9.32%
13.96%
0.00
-4.64%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 3,620.87 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 12.81% vs 4.17% in Sep 2024
Half Yearly - Consolidate Net Profit
Consolidate Net Profit 339.09 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 17.69% vs 12.04% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 597.04 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 25.40% vs 16.99% in Sep 2024
Half Yearly - Interest
Interest 47.75 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 49.27% vs 6.35% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.49%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
